U.S. Sen. Alex Padilla visited UC Irvine on September 8 to learn about the university's contributions to health and innovation through its research. The visit focused on how campus research is advancing the search for new treatments for Alzheimer’s disease and other forms of dementia.
Senator Padilla met with campus leaders for presentations covering UC Irvine’s research portfolio, UCI Health, Beall Applied Innovation, and UCI MIND. Following these discussions, he toured a UCI MIND laboratory. UCI MIND functions as UC Irvine’s interdisciplinary research center, dedicated to understanding, diagnosing, treating, and ultimately preventing Alzheimer’s disease and other forms of dementia.
Aileen Anderson, vice chancellor for research, emphasized the importance of sustained federal investment in university research during the discussions. Anderson explained that uncertainty in the funding pipeline can create difficulties in maintaining laboratories, research programs, and opportunities for students. She also noted the critical role academic research centers play in transitioning discoveries from basic research through clinical trials and ultimately to patients.
Dr. Michael Stamos, interim vice chancellor for health affairs and dean of the School of Medicine, provided insights into UCI Health’s expanding network of hospitals and clinics. He detailed UC Irvine’s four health sciences schools, which encompass medicine, nursing, pharmacy, and public health. Stamos described how robust translational and clinical research in these areas is leading to new discoveries, products, treatments, and cures, while also preparing the future healthcare workforce.
Errol Arkilic, UC Irvine’s chief innovation officer, showcased the university’s infrastructure designed to translate research discoveries into commercial products and services. Arkilic highlighted efforts to move innovations from the laboratory to the marketplace, specifically mentioning areas such as medical devices, artificial intelligence, aerospace, and national security. He also provided examples of UC Irvine technologies that are moving toward commercialization.
Joshua Grill, director of UCI MIND, offered an update on advancements in Alzheimer’s research. His presentation included progress in PET imaging, the development of blood-based testing, and new treatment methodologies. Grill also discussed ongoing efforts to increase Latino participation in clinical trials for Alzheimer’s disease.
Senator Padilla commented on the significance of federally funded research at universities, stating that it “helps shape the future of health and technology.” He specifically acknowledged the work at the UCI MIND laboratory, where researchers are advancing medical breakthroughs. Padilla expressed his interest in understanding how Congress can support research that makes a meaningful difference for patients and families affected by Alzheimer’s disease and other forms of dementia.
Anderson concluded by expressing appreciation for the opportunity to welcome Senator Padilla to UC Irvine. She reiterated how university research is making a difference in people’s daily lives and thanked the senator for his interest in hearing directly from researchers about their work and the role public research universities play in improving the health and quality of life for Americans. The visit served as an occasion for UC Irvine to demonstrate the impact of its research on public health and quality of life.
